How Effective Is Neoadjuvant Therapy Followed by Surgery for Pathologic Single-Station N2 Non-Small Cell Lung Cancer?

OBJECTIVE: The optimal treatment strategy for pathologic single-station N2 (pN2a1) non-small cell lung cancer (NSCLC)—surgery first followed by adjuvant treatment (SF) or neoadjuvant therapy followed by surgery (NS)—remains unclear. We compared disease-free survival (DFS) and overall survival (OS) a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Semin Thorac Cardiovasc Surg
Main Authors: Keshava, Hari B., Tan, Kay See, Dycoco, Joseph, Livschitz, Jennifer, Bott, Matthew J., Huang, James, Rusch, Valerie W., Isbell, James M., Molena, Daniela, Bains, Manjit S., Jones, David R., Rocco, Gaetano
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904958/
https://ncbi.nlm.nih.gov/pubmed/32853736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.semtcvs.2020.08.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados